Skip to main content

Table 2 Characteristics of patients with refractory disease

From: Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series

Patient Regimen Duration of therapy (mos) UPCR 6 months before RCP UPCR at RCP initiation
1 MMF & Pred 12 5.2 10.7
2 CsA & Pred 18 NA 11.9
3 CsA & Pred 6 6.8 16.7
  1. Abbreviations: CsA cyclosporine, MMF mycophenolate mofetil, mos months, NA not available, Pred prednisone, UPCR urinary protein: creatinine ratio, RCP rituximab, cyclophosphamide, prednisone